PDSB PDS Biotechnology Corporation

Fundamentals / CIK 0001472091 / USD

PDS Biotechnology Corporation reported $18.57M in total assets and a net loss of $32.28M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PDSB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$47.55MFY 2016 Net Income: -$38.82M2016FY 2017 Net Income: -$50.86M2017FY 2018 Net Income: -$3.84M2018FY 2019 Net Income: -$7.00M2019FY 2020 Net Income: -$14.85M2020FY 2021 Net Income: -$16.92M2021FY 2022 Net Income: -$40.85M2022FY 2023 Net Income: -$42.94M2023FY 2024 Net Income: -$37.61M2024FY 2025 Net Income: -$34.50M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $19.03M $22.57M $27.76M $29.43M $11.25M $7.92M $6.10M $831K $34.31M $24.83M
Total Operating Expenses $31.54M $36.32M $43.05M $41.67M $21.44M $14.90M $21.03M $3.65M $51.97M $39.51M
Operating Income -$31.54M -$36.32M -$43.05M -$41.67M -$21.44M -$14.90M -$21.03M -$3.65M -$51.97M -$39.51M
EBITDA -$31.52M -$36.30M -$43.03M -$41.67M -$21.43M -$14.89M -$20.94M -$3.58M -$51.78M -$39.41M
Interest Income $1.22M $2.51M $2.90M $935K $4.3K $55K $353K $0 -- --
Interest Expense $5.34M $4.67M $4.21M $1.32M $0 $0 $34K $3.6K $2.18M $1.20M
Income Before Tax -$35.67M -$38.48M -$44.35M -$42.05M -$21.43M -$14.85M -$7.38M -$3.84M -$53.45M -$40.67M
Income Tax Expense -$1.17M -$869K -$1.41M -$1.20M -$4.52M $0 -$382K $0 -$2.59M -$1.85M
Net Income -$34.50M -$37.61M -$42.94M -$40.85M -$16.92M -$14.85M -$7.00M -$3.84M -$50.86M -$38.82M
Basic EPS -$0.74 -$1.03 -$1.39 -$1.43 -$0.66 -$0.89 -$1.44 $1.15 -- --
Diluted EPS -$0.74 -$1.03 -$1.39 -$1.43 -$0.66 -$0.89 -$1.44 $1.15 -- --
Basic Shares Outstanding 46.4M 36.5M 31.0M 28.6M 25.6M 16.7M 4.9M 3.3M 1.5M 1.4M
Diluted Shares Outstanding 46.4M 36.5M 31.0M 28.6M 25.6M 16.7M 4.9M 3.3M 1.5M 1.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.05M $3.27M $3.46M $4.41M $4.58M $4.21M $5.83M $4.53M
Total Operating Expenses $5.90M $6.50M $6.52M $6.67M $8.14M $7.62M $9.11M $7.36M
Operating Income -$5.90M -$6.50M -$6.52M -$6.67M -$8.14M -$7.62M -$9.11M -$7.36M
EBITDA -$5.89M -$6.49M -$6.52M -$6.67M -$8.13M -$7.62M -$9.10M -$7.36M
Interest Income $42K $125K $187K $225K $281K $334K $378K $504K
Interest Expense $1.77M $3.38M $1.01M $1.11M $1.15M $2.14M $931K $1.10M
Income Before Tax -$7.62M -$9.75M -$7.35M -$7.56M -$9.01M -$9.43M -$9.66M -$7.95M
Income Tax Expense $0 $0 $0 $0 $0 $0 -$1.17M $0
Net Income -$7.62M -$9.75M -$7.35M -$7.56M -$9.01M -$9.43M -$8.49M -$7.95M
Basic EPS -$0.11 -$0.18 -$0.13 -- -$0.19 -$0.21 -$0.21 --
Diluted EPS -$0.11 -$0.18 -$0.13 -- -$0.19 -$0.21 -$0.21 --
Basic Shares Outstanding 71.9M 55.7M 55.5M -- 46.9M 45.9M 40.5M --
Diluted Shares Outstanding 71.9M 55.7M 55.5M -- 46.9M 45.9M 40.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $26.71M $41.69M $56.56M $73.82M $65.24M $28.84M $12.16M $104K $88.07M $106.4M
Cash & Short-Term Investments $26.71M $41.69M $56.56M $73.82M $65.24M $28.84M $12.16M $104K $88.07M $106.4M
Total Current Assets $28.25M $45.05M $59.06M $76.48M $66.84M $30.34M $14.47M $122K $89.05M $107.4M
Property, Plant & Equipment, Net $120K $142K $134K $0 $86 $5.4K $21K $30K $3.42M $3.42M
Intangible Assets -- -- -- -- -- $2.97M $2.97M $0 -- --
Other Non-Current Assets -- -- -- -- -- -- $0 $13K $143K $143K
Total Non-Current Assets $2.24M $304K $335K $528K $358K $553K $21K $42K $3.57M $3.56M
Total Assets $30.49M $45.36M $59.39M $77.01M $67.20M $30.89M $14.49M $164K $92.62M $110.9M
Accounts Payable $3.57M $1.68M $6.98M $1.22M $1.31M $1.42M $1.20M $1.31M $4.37M $3.47M
Total Current Liabilities $9.48M $17.09M $13.63M $9.82M $3.76M $3.27M $2.79M $1.91M $12.87M $6.68M
Total Non-Current Liabilities $11.76M $9.27M $19.63M $23.18M $231K $490K $0 $321K $80.36M $14.95M
Total Liabilities $21.24M $26.35M $33.26M $33.01M $3.99M $3.76M $2.79M $2.23M $93.23M $21.64M
Total Debt (incl. Leases) $62K $123K $179K $452K $490K $610K -- -- -- --
Common Stock $18K $13K $11K $10.0K $9.4K $7.3K $1.7K $1.1K $10K $9.8K
Retained Earnings -$216.6M -$182.1M -$144.5M -$101.6M -$60.70M -$43.79M -$28.94M -$21.94M -$151.9M -$101.1M
Total Stockholders' Equity $9.25M $19.00M $26.13M $44.00M $63.21M $27.13M $11.70M -$2.07M -$610K $89.28M
Total Equity $9.25M $19.00M $26.13M $44.00M $63.21M $27.13M $11.70M -$2.07M -$610K $89.28M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $15.25M $5.60M $21.66M $26.71M $26.20M $31.87M $39.98M $41.69M
Cash & Short-Term Investments $15.25M $5.60M $21.66M $26.71M $26.20M $31.87M $39.98M $41.69M
Total Current Assets $18.37M $7.05M $22.89M $28.25M $27.89M $33.65M $42.47M $45.05M
Property, Plant & Equipment, Net $168K $177K $115K $120K $126K $131K $137K $142K
Total Non-Current Assets $198K $1.76M $1.78M $2.24M $6.81M $6.83M $4.56M $304K
Total Assets $18.57M $8.81M $24.66M $30.49M $34.71M $40.48M $47.03M $45.36M
Accounts Payable $2.99M $6.39M $3.65M $3.57M $5.18M $4.50M $2.86M $1.68M
Total Current Liabilities $5.08M $12.38M $10.15M $9.48M $13.33M $11.53M $18.27M $17.09M
Total Non-Current Liabilities $1.1K $9.5K $10.62M $11.76M $11.92M $12.98M $6.40M $9.27M
Total Liabilities $5.08M $12.39M $20.77M $21.24M $25.25M $24.52M $24.67M $26.35M
Total Debt (incl. Leases) $34K $41K $49K $62K $78K $93K $108K $123K
Common Stock $34K $18K $18K $18K $16K $15K $15K $13K
Retained Earnings -$241.3M -$233.7M -$224.0M -$216.6M -$209.0M -$200.0M -$190.6M -$182.1M
Total Stockholders' Equity $13.50M -$3.58M $3.89M $9.25M $9.45M $15.96M $22.36M $19.00M
Total Equity $13.50M -$3.58M $3.89M $9.25M $9.45M $15.96M $22.36M $19.00M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$34.50M -$37.61M -$42.94M -$40.85M -$16.92M -$14.85M -$7.00M -$3.84M -$50.86M -$38.82M
Depreciation & Amortization $22K $21K $17K $86 $5.4K $16K $98K $69K $183K $100K
Stock-Based Compensation $4.11M $6.85M $7.61M $5.20M $4.07M $432K $3.14M $867K $6.18M $5.31M
Change in Payables $1.89M -$5.30M $5.76M -$90K -$106K $218K -$1.98M $789K $898K $1.42M
Operating Cash Flow -$27.75M -$35.03M -$33.64M -$25.71M -$12.49M -$13.15M -$18.07M -$1.57M -$40.70M -$32.19M
Capital Expenditure $0 -$29K $0 -- -- -- -- $0 -$189K -$687K
Free Cash Flow -$27.75M -$35.06M -$33.64M -- -- -- -- -$1.57M -$40.89M -$32.88M
Investing Cash Flow $0 -$29K $0 -- -- $0 $29.38M $0 -$189K -$687K
Common Stock Issued $9.71M $0 $16.13M $9.86M $48.54M $29.76M $750K $1.28M -- --
Financing Cash Flow $12.77M $20.19M $16.38M $34.29M $48.89M $29.83M $750K $1.50M $22.55M $9.08M
Net Change in Cash -$14.98M -$14.87M -$17.26M $8.58M $36.40M $16.68M $12.06M -$53.42M -$18.33M -$23.79M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.62M -$9.75M -$7.35M -$7.56M -$9.01M -$9.43M -$8.49M -$7.95M
Depreciation & Amortization $8.4K $8.4K $5.5K $5.5K $5.5K $5.5K $5.5K $5.5K
Stock-Based Compensation $840K $1.13M $1.16M $1.16M $1.25M $448K $1.25M $1.64M
Change in Payables -$3.40M $2.74M $76K -$1.61M $683K $1.64M $1.17M $384K
Operating Cash Flow -$8.22M -$2.79M -$4.37M -$3.70M -$5.92M -$9.10M -$9.03M -$8.23M
Common Stock Issued $2.51M $0 $0 $2.71M $0 $0 $6.99M $0
Financing Cash Flow $17.87M -$13.27M -$680K $4.22M $241K $996K $7.32M $173K
Net Change in Cash $9.65M -$16.06M -$5.05M $513K -$5.67M -$8.11M -$1.71M -$8.06M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -372.9% -197.9% -164.3% -92.8% -26.8% -54.7% -59.8% -- -- -43.5%
Return on Assets (ROA) -113.1% -82.9% -72.3% -53.1% -25.2% -48.1% -48.3% -2333.2% -54.9% -35.0%
Current Ratio 2.98x 2.64x 4.33x 7.79x 17.80x 9.28x 5.18x 0.06x 6.92x 16.06x
Quick Ratio 2.82x 2.44x 4.15x 7.52x 17.37x 8.82x 4.35x 0.05x 6.84x 15.92x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.02x -- -- -- --
EPS Growth (YoY) -- -- -- -- -- -- -225.2% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -239.2% -- -856.9% -372.9% -369.0% -229.3% -158.7% -197.9%
Return on Assets (ROA) -173.8% -382.3% -135.2% -113.1% -100.5% -90.4% -75.5% -82.9%
Current Ratio 3.62x 0.57x 2.26x 2.98x 2.09x 2.92x 2.33x 2.64x
Quick Ratio 3.00x 0.45x 2.13x 2.82x 1.97x 2.76x 2.19x 2.44x
Debt to Equity 0.00x -- 0.01x 0.01x 0.01x 0.01x 0.00x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001472091) · from December 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal